Endocrine Cancer

ENDOCRINE CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Multidisciplinary Genetic Tumor Boards: Critical for Interpreting Tumor-Only Sequencing Results

One approach for improving recommendations based on tumor-only sequencing is use of a multidisciplinary genomic tumor board, in which researchers from a variety of backgrounds weigh in on the best way to interpret test results.
In-House or Centralized Testing? Debating Whether Genomic Sequencing Is Best Conducted at Home

Genomic analysis of tumors and tests measuring certain biomarkers can be done in-house or sent out. What are the costs and benefits of each approach?
What Do Surrogate End Points Actually Predict?

As understanding of cancer improves, drug development could become accelerated, necessitating a means for determining whether a drug is actually effective.
Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns

Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.
A Novel Method for Biomarker Discovery in Clinical Trials

A new study reveals a unique method of biomarker discovery that has the potential to be used to identify responder subpopulations in clinical trials.

ENDOCRINE CANCER NEWS

Once-Weekly Exenatide Treatment Does Not Increase Risk for Medullary Thyroid Carcinoma

May 14, 2019

Cumulative Risk for Thyroid Cancer After Initial Benign Thyroid Biopsy

May 8, 2019

There is a push to create innovative adaptive trial designs that include more patients and, subseque

Lenvatinib Active in Rare Adenoid Cystic Carcinoma

April 25, 2019

Gastrinomas, rare endocrine tumors, can be treated in multiple ways, regardless of whether the tumor

High Response Rate for Patients With High-Grade Neuroendocrine Cancer Receiving Dual Immune Checkpoint Blockade

April 1, 2019

The continuous decline in cancer deaths over the past 25 years was attributed to improvements in scr

Vitiligo May Be Associated With Reduced Risk of Internal Cancer

March 18, 2019

Next post in Endocrine Cancer

Cumulative Risk for Thyroid Cancer After Initial Benign Thyroid Biopsy